Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 2
2007 2
2008 4
2009 4
2010 5
2011 5
2012 3
2013 3
2014 6
2015 3
2016 5
2017 3
2018 6
2019 12
2020 15
2021 19
2022 17
2023 32
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
Peng J, Fan M, An C, Ni F, Huang W, Luo J. Peng J, et al. Basic Clin Pharmacol Toxicol. 2022 Apr;130(4):439-456. doi: 10.1111/bcpt.13710. Epub 2022 Feb 6. Basic Clin Pharmacol Toxicol. 2022. PMID: 35083862 Free article. Review.
Cannabidiol (CBD) is an abundant non-psychoactive phytocannabinoid in cannabis extracts which has high affinity on a series of receptors, including Type 1 cannabinoid receptor (CB1), Type 2 cannabinoid receptor (CB2), GPR55, transient receptor potential vanilloid (TRPV) an …
Cannabidiol (CBD) is an abundant non-psychoactive phytocannabinoid in cannabis extracts which has high affinity on a series of recept …
The therapeutic potential of purified cannabidiol.
O'Sullivan SE, Jensen SS, Nikolajsen GN, Bruun HZ, Bhuller R, Hoeng J. O'Sullivan SE, et al. J Cannabis Res. 2023 Jun 13;5(1):21. doi: 10.1186/s42238-023-00186-9. J Cannabis Res. 2023. PMID: 37312194 Free PMC article. Review.
The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention, with speculation that CBD can be useful in a wide range of conditions. ...Current RCT evidence does not support the use of purified oral CBD in pain (at least as an acute analgesic) …
The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention, with speculation that CBD can be useful in …
Cannabidiol.
[No authors listed] [No authors listed] 2023 Feb 16. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2023 Feb 16. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644197 Free Books & Documents. Review.
High daily doses of cannabidiol are associated with frequent serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent liver injury with jaundice. The lower doses of cannabidiol found typically in over-the-counter CBD products a …
High daily doses of cannabidiol are associated with frequent serum enzyme elevations during therapy, but has not been linked to cases …
The pharmacology and therapeutic role of cannabidiol in diabetes.
Zhang J, Lin C, Jin S, Wang H, Wang Y, Du X, Hutchinson MR, Zhao H, Fang L, Wang X. Zhang J, et al. Exploration (Beijing). 2023 Jul 12;3(5):20230047. doi: 10.1002/EXP.20230047. eCollection 2023 Oct. Exploration (Beijing). 2023. PMID: 37933286 Free PMC article.
CBD has demonstrated significant therapeutic potential in treating diabetes mellitus and its complications owing to its various pharmacological effects. This work summarizes the role of CBD in diabetes and its impact on complications such as cardiovascular dy …
CBD has demonstrated significant therapeutic potential in treating diabetes mellitus and its complications owing to its variou …
The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease.
Kicman A, Toczek M. Kicman A, et al. Int J Mol Sci. 2020 Sep 14;21(18):6740. doi: 10.3390/ijms21186740. Int J Mol Sci. 2020. PMID: 32937917 Free PMC article. Review.
Cannabidiol (CBD) is a non-intoxicating and generally well-tolerated constituent of cannabis which exhibits potential beneficial properties in a wide range of diseases, including cardiovascular disorders. ...Many positive effects of CBD have been observed in experimental m …
Cannabidiol (CBD) is a non-intoxicating and generally well-tolerated constituent of cannabis which exhibits potential beneficial prop …
The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities.
Xu DH, Cullen BD, Tang M, Fang Y. Xu DH, et al. Curr Pharm Biotechnol. 2020;21(5):390-402. doi: 10.2174/1389201020666191202111534. Curr Pharm Biotechnol. 2020. PMID: 31793418 Clinical Trial.
There has, however, been an increasing body of evidence for the use of cannabinoids in the treatment of chronic, noncancer pain. The efficacy of a topically delivered cannabidiol (CBD) oil in the management of neuropathic pain was examined in this four-week, randomized and …
There has, however, been an increasing body of evidence for the use of cannabinoids in the treatment of chronic, noncancer pain. The efficac …
Cannabidiol (CBD) Use in Type 2 Diabetes: A Case Report.
Mattes RG, Espinosa ML, Oh SS, Anatrella EM, Urteaga EM. Mattes RG, et al. Diabetes Spectr. 2021 May;34(2):198-201. doi: 10.2337/ds20-0023. Epub 2021 Dec 23. Diabetes Spectr. 2021. PMID: 34149261 Free PMC article. No abstract available.
The role of cannabinoids in pain modulation in companion animals.
Miranda-Cortés A, Mota-Rojas D, Crosignani-Outeda N, Casas-Alvarado A, Martínez-Burnes J, Olmos-Hernández A, Mora-Medina P, Verduzco-Mendoza A, Hernández-Ávalos I. Miranda-Cortés A, et al. Front Vet Sci. 2023 Jan 4;9:1050884. doi: 10.3389/fvets.2022.1050884. eCollection 2022. Front Vet Sci. 2023. PMID: 36686189 Free PMC article. Review.
Nonetheless, the availability and therapeutic use of naturally occurring or synthetic phytocannabinoids, such as delta(9)-tetrahydrocannabidiol and cannabidiol, have been the focus of attention in studies regarding their medical uses. ...However, the endocannabinoid system …
Nonetheless, the availability and therapeutic use of naturally occurring or synthetic phytocannabinoids, such as delta(9)-tetrahydrocannabid …
Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.
Santiago AN, Mori MA, Guimarães FS, Milani H, Weffort de Oliveira RM. Santiago AN, et al. Neurotox Res. 2019 Feb;35(2):463-474. doi: 10.1007/s12640-018-9972-5. Epub 2018 Nov 14. Neurotox Res. 2019. PMID: 30430393
Cannabidiol (CBD) is a phytocannabinoid present in the Cannabis sativa plant. ...Cannabidiol attenuated the decrease in hippocampal levels of brain-derived neurotrophic factor induced by CCH in diabetic animals, but it did not affect the levels of neuroplasti …
Cannabidiol (CBD) is a phytocannabinoid present in the Cannabis sativa plant. ...Cannabidiol attenuated the decrease in hippoc …
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis.
Zheng T, BouSaba J, Taylor A, Dilmaghani S, Busciglio I, Carlson P, Torres M, Ryks M, Burton D, Harmsen WS, Camilleri M. Zheng T, et al. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3405-3414.e4. doi: 10.1016/j.cgh.2023.07.008. Epub 2023 Jul 22. Clin Gastroenterol Hepatol. 2023. PMID: 37482172 Clinical Trial.
We compared the effects of 4 weeks of treatment with pharmaceutical CBD vs placebo in patients with idiopathic or diabetic (diabetes mellitus) gastroparesis. METHODS: We performed a randomized, double-blinded, placebo-controlled study of CBD twice daily (Epid …
We compared the effects of 4 weeks of treatment with pharmaceutical CBD vs placebo in patients with idiopathic or diabetic (diabet …
138 results